Sterile Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
249 Pages
January 2024
Region: Global
Fairfield Market Research
ID: 5934378

The Sterile Injectable Drugs Market is a critical and dynamic sector within the pharmaceutical industry, playing a pivotal role in the treatment of various medical conditions. Sterile injectable drugs are pharmaceutical products that are administered through injections, intravenously or intramuscularly, to deliver precise and rapid therapeutic effects. These drugs are manufactured under strict sterile conditions to ensure patient safety and product efficacy.

The market's significance lies in its ability to provide rapid relief and precise dosing, making it indispensable in emergency situations, critical care, and treatments where oral medication is not viable. Sterile injectable drugs encompass a broad spectrum of therapeutic categories, including antibiotics, antivirals, vaccines, cancer therapies, and pain management drugs, among others.

The increasing prevalence of chronic diseases, aging populations, and advancements in medical technology are driving the demand for sterile injectable drugs. Additionally, the ongoing research and development efforts to expand the range of available treatments further contribute to the market's growth.

However, stringent regulatory requirements and the need for specialized manufacturing facilities pose challenges to market players. Nonetheless, with the continuous expansion of healthcare infrastructure and the rising focus on patient care and safety, the Sterile Injectable Drugs Market is poised for sustained growth and innovation in the coming years.

High operational costs and discontinuation of products is anticipated to hinder revenue growth of the global sterile injectable drugs market

The growth of revenue in the global sterile injectable drugs market is hindered by high operational costs and the discontinuation of injectable drugs for cancer treatment worldwide. The manufacturing of sterile drugs involves complex equipment, stringent certification, and sterilization requirements, leading to elevated operating costs and increased debt levels. Additionally, compliance with FDA regulations for maintaining high standards in the production, packaging, storage, and distribution of sterile injectable drugs contributes to high regulatory costs. This, in turn, impedes revenue growth in the market. The cancer segment is particularly affected by competition from low-cost manufacturers, resulting in the discontinuation of several products. Large pharmaceutical companies consolidating the supply chain have also led to the closure of manufacturing sites, negatively impacting both the cancer segment and the overall global sterile injectable drugs market.

Demand for oncology drugs through sterile injections is expected to boost market growth in Europe

The cancer segment led the North America sterile injectable drugs market in revenue in 2024 and is expected to maintain this dominance throughout the forecast period. With an attractiveness index of 1.2, the cancer segment is considered the most appealing market segment. The demand for injectable drugs in oncology is on the rise in North America. Europe is also witnessing growth in sterile injectable drugs for cancer due to increased demand for injectable formats. In Africa, factors like poor healthcare access, malnutrition, poverty, and a warm climate drive the demand for essential medicines in sterile injectable formats for faster cancer treatment.

Key player strategies in the global sterile injectable drugs market

Companies in the global sterile injectable drugs market are actively consolidating their market presence through acquisitions of both small and large injectable firms. A key strategy involves expanding manufacturing capacities to attain economies of scale. Additionally, these companies are strategically targeting diverse global markets to enhance their geographic footprint in the sterile injectable drugs market

Key Companies Profiled

Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc.
AstraZeneca
GILEAD SCIENCES, INC.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson Services, Inc.
Nova Nordisk A/S

Global Sterile Injectable Drugs Market Segmentation

By Drug Type

Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Blood Factors
Vaccines
Immunoglobulins
Peptide Antibiotics
Others

By Application

Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others

By Route of Administration

Intravenous (IV)
Intramuscular (IM)
Subcutaneous (SC)
Others

By Molecule Type

Small Molecules
Large Molecules

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region

North America
Latin America
Europe
Asia Pacific
MEA

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Sterile Injectable Drugs Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Sterile Injectable Drugs Market Outlook, 2018 - 2031

3.1. Global Sterile Injectable Drugs Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Monoclonal Antibodies
3.1.1.2. Cytokines
3.1.1.3. Insulin
3.1.1.4. Peptide Hormones
3.1.1.5. Blood Factors
3.1.1.6. Vaccines
3.1.1.7. Immunoglobulins
3.1.1.8. Peptide Antibiotics
3.1.1.9. Others
3.2. Global Sterile Injectable Drugs Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Cancer
3.2.1.2. Diabetes
3.2.1.3. Cardiovascular Diseases
3.2.1.4. Musculoskeletal
3.2.1.5. CNS
3.2.1.6. Infections
3.2.1.7. Others
3.3. Global Sterile Injectable Drugs Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Intravenous (IV)
3.3.1.2. Intramuscular (IM)
3.3.1.3. Subcutaneous (SC)
3.3.1.4. Others
3.4. Global Sterile Injectable Drugs Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Small Molecules
3.4.1.2. Large Molecules
3.5. Global Sterile Injectable Drugs Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. Hospital Pharmacies
3.5.1.2. Retail Pharmacies
3.5.1.3. Online Pharmacies
3.6. Global Sterile Injectable Drugs Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.6.1. Key Highlights
3.6.1.1. North America
3.6.1.2. Europe
3.6.1.3. Asia Pacific
3.6.1.4. Latin America
3.6.1.5. Middle East & Africa

4. North America Sterile Injectable Drugs Market Outlook, 2018 - 2031

4.1. North America Sterile Injectable Drugs Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Monoclonal Antibodies
4.1.1.2. Cytokines
4.1.1.3. Insulin
4.1.1.4. Peptide Hormones
4.1.1.5. Blood Factors
4.1.1.6. Vaccines
4.1.1.7. Immunoglobulins
4.1.1.8. Peptide Antibiotics
4.1.1.9. Others
4.2. North America Sterile Injectable Drugs Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Cancer
4.2.1.2. Diabetes
4.2.1.3. Cardiovascular Diseases
4.2.1.4. Musculoskeletal
4.2.1.5. CNS
4.2.1.6. Infections
4.2.1.7. Others
4.3. North America Sterile Injectable Drugs Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Intravenous (IV)
4.3.1.2. Intramuscular (IM)
4.3.1.3. Subcutaneous (SC)
4.3.1.4. Others
4.4. North America Sterile Injectable Drugs Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Small Molecules
4.4.1.2. Large Molecules
4.5. North America Sterile Injectable Drugs Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. Hospital Pharmacies
4.5.1.2. Retail Pharmacies
4.5.1.3. Online Pharmacies
4.6. North America Sterile Injectable Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.6.1. Key Highlights
4.6.1.1. U.S. Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
4.6.1.2. U.S. Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
4.6.1.3. U.S. Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
4.6.1.4. U.S. Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
4.6.1.5. U.S. Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.6.1.6. Canada Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
4.6.1.7. Canada Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
4.6.1.8. Canada Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
4.6.1.9. Canada Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
4.6.1.10. Canada Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.6.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Sterile Injectable Drugs Market Outlook, 2018 - 2031

5.1. Europe Sterile Injectable Drugs Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Monoclonal Antibodies
5.1.1.2. Cytokines
5.1.1.3. Insulin
5.1.1.4. Peptide Hormones
5.1.1.5. Blood Factors
5.1.1.6. Vaccines
5.1.1.7. Immunoglobulins
5.1.1.8. Peptide Antibiotics
5.1.1.9. Others
5.2. Europe Sterile Injectable Drugs Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Cancer
5.2.1.2. Diabetes
5.2.1.3. Cardiovascular Diseases
5.2.1.4. Musculoskeletal
5.2.1.5. CNS
5.2.1.6. Infections
5.2.1.7. Others
5.3. Europe Sterile Injectable Drugs Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Intravenous (IV)
5.3.1.2. Intramuscular (IM)
5.3.1.3. Subcutaneous (SC)
5.3.1.4. Others
5.4. Europe Sterile Injectable Drugs Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Small Molecules
5.4.1.2. Large Molecules
5.5. Europe Sterile Injectable Drugs Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Hospital Pharmacies
5.5.1.2. Retail Pharmacies
5.5.1.3. Online Pharmacies
5.6. Europe Sterile Injectable Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.6.1. Key Highlights
5.6.1.1. Germany Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.6.1.2. Germany Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
5.6.1.3. Germany Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.4. Germany Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
5.6.1.5. Germany Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.6. U.K. Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.6.1.7. U.K. Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
5.6.1.8. U.K. Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.9. U.K. Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
5.6.1.10. U.K. Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.11. France Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.6.1.12. France Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
5.6.1.13. France Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.14. France Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
5.6.1.15. France Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.16. Italy Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.6.1.17. Italy Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
5.6.1.18. Italy Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.19. Italy Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
5.6.1.20. Italy Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.21. Turkey Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.6.1.22. Turkey Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
5.6.1.23. Turkey Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.24. Turkey Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
5.6.1.25. Turkey Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.26. Russia Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.6.1.27. Russia Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
5.6.1.28. Russia Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.29. Russia Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
5.6.1.30. Russia Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.1.31. Rest of Europe Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
5.6.1.32. Rest of Europe Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
5.6.1.33. Rest of Europe Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
5.6.1.34. Rest of Europe Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
5.6.1.35. Rest of Europe Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.6.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Sterile Injectable Drugs Market Outlook, 2018 - 2031

6.1. Asia Pacific Sterile Injectable Drugs Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Monoclonal Antibodies
6.1.1.2. Cytokines
6.1.1.3. Insulin
6.1.1.4. Peptide Hormones
6.1.1.5. Blood Factors
6.1.1.6. Vaccines
6.1.1.7. Immunoglobulins
6.1.1.8. Peptide Antibiotics
6.1.1.9. Others
6.2. Asia Pacific Sterile Injectable Drugs Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Cancer
6.2.1.2. Diabetes
6.2.1.3. Cardiovascular Diseases
6.2.1.4. Musculoskeletal
6.2.1.5. CNS
6.2.1.6. Infections
6.2.1.7. Others
6.3. Asia Pacific Sterile Injectable Drugs Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Intravenous (IV)
6.3.1.2. Intramuscular (IM)
6.3.1.3. Subcutaneous (SC)
6.3.1.4. Others
6.4. Asia Pacific Sterile Injectable Drugs Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Small Molecules
6.4.1.2. Large Molecules
6.5. Asia Pacific Sterile Injectable Drugs Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. Hospital Pharmacies
6.5.1.2. Retail Pharmacies
6.5.1.3. Online Pharmacies
6.6. Asia Pacific Sterile Injectable Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.6.1. Key Highlights
6.6.1.1. China Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.6.1.2. China Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
6.6.1.3. China Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.4. China Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
6.6.1.5. China Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.6. Japan Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.6.1.7. Japan Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
6.6.1.8. Japan Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.9. Japan Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
6.6.1.10. Japan Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.11. South Korea Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.6.1.12. South Korea Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
6.6.1.13. South Korea Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.14. South Korea Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
6.6.1.15. South Korea Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.16. India Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.6.1.17. India Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
6.6.1.18. India Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.19. India Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
6.6.1.20. India Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.21. Southeast Asia Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.6.1.22. Southeast Asia Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
6.6.1.23. Southeast Asia Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.24. Southeast Asia Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
6.6.1.25. Southeast Asia Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.1.26. Rest of Asia Pacific Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
6.6.1.27. Rest of Asia Pacific Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
6.6.1.28. Rest of Asia Pacific Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
6.6.1.29. Rest of Asia Pacific Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
6.6.1.30. Rest of Asia Pacific Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Sterile Injectable Drugs Market Outlook, 2018 - 2031

7.1. Latin America Sterile Injectable Drugs Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Monoclonal Antibodies
7.1.1.2. Cytokines
7.1.1.3. Insulin
7.1.1.4. Peptide Hormones
7.1.1.5. Blood Factors
7.1.1.6. Vaccines
7.1.1.7. Immunoglobulins
7.1.1.8. Peptide Antibiotics
7.1.1.9. Others
7.2. Latin America Sterile Injectable Drugs Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Cancer
7.2.1.2. Diabetes
7.2.1.3. Cardiovascular Diseases
7.2.1.4. Musculoskeletal
7.2.1.5. CNS
7.2.1.6. Infections
7.2.1.7. Others
7.3. Latin America Sterile Injectable Drugs Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Intravenous (IV)
7.3.1.2. Intramuscular (IM)
7.3.1.3. Subcutaneous (SC)
7.3.1.4. Others
7.4. Latin America Sterile Injectable Drugs Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Small Molecules
7.4.1.2. Large Molecules
7.5. Latin America Sterile Injectable Drugs Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Hospital Pharmacies
7.5.1.2. Retail Pharmacies
7.5.1.3. Online Pharmacies
7.6. Latin America Sterile Injectable Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.6.1. Key Highlights
7.6.1.1. Brazil Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.6.1.2. Brazil Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
7.6.1.3. Brazil Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.4. Brazil Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
7.6.1.5. Brazil Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.6. Mexico Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.6.1.7. Mexico Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
7.6.1.8. Mexico Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.9. Mexico Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
7.6.1.10. Mexico Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.11. Argentina Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.6.1.12. Argentina Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
7.6.1.13. Argentina Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.14. Argentina Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
7.6.1.15. Argentina Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.1.16. Rest of Latin America Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
7.6.1.17. Rest of Latin America Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
7.6.1.18. Rest of Latin America Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
7.6.1.19. Rest of Latin America Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
7.6.1.20. Rest of Latin America Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Sterile Injectable Drugs Market Outlook, 2018 - 2031

8.1. Middle East & Africa Sterile Injectable Drugs Market Outlook, by Drug Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Monoclonal Antibodies
8.1.1.2. Cytokines
8.1.1.3. Insulin
8.1.1.4. Peptide Hormones
8.1.1.5. Blood Factors
8.1.1.6. Vaccines
8.1.1.7. Immunoglobulins
8.1.1.8. Peptide Antibiotics
8.1.1.9. Others
8.2. Middle East & Africa Sterile Injectable Drugs Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Cancer
8.2.1.2. Diabetes
8.2.1.3. Cardiovascular Diseases
8.2.1.4. Musculoskeletal
8.2.1.5. CNS
8.2.1.6. Infections
8.2.1.7. Others
8.3. Middle East & Africa Sterile Injectable Drugs Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Intravenous (IV)
8.3.1.2. Intramuscular (IM)
8.3.1.3. Subcutaneous (SC)
8.3.1.4. Others
8.4. Middle East & Africa Sterile Injectable Drugs Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Small Molecules
8.4.1.2. Large Molecules
8.5. Middle East & Africa Sterile Injectable Drugs Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. Hospital Pharmacies
8.5.1.2. Retail Pharmacies
8.5.1.3. Online Pharmacies
8.6. Middle East & Africa Sterile Injectable Drugs Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.6.1. Key Highlights
8.6.1.1. GCC Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.6.1.2. GCC Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
8.6.1.3. GCC Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.4. GCC Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
8.6.1.5. GCC Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.6. South Africa Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.6.1.7. South Africa Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
8.6.1.8. South Africa Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.9. South Africa Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
8.6.1.10. South Africa Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.11. Egypt Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.6.1.12. Egypt Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
8.6.1.13. Egypt Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.14. Egypt Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
8.6.1.15. Egypt Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.16. Nigeria Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.6.1.17. Nigeria Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
8.6.1.18. Nigeria Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.19. Nigeria Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
8.6.1.20. Nigeria Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.1.21. Rest of Middle East & Africa Sterile Injectable Drugs Market by Drug Type, Value (US$ Bn), 2018 - 2031
8.6.1.22. Rest of Middle East & Africa Sterile Injectable Drugs Market by Application, Value (US$ Bn), 2018 - 2031
8.6.1.23. Rest of Middle East & Africa Sterile Injectable Drugs Market by Route of Administration, Value (US$ Bn), 2018 - 2031
8.6.1.24. Rest of Middle East & Africa Sterile Injectable Drugs Market by Molecule Type, Value (US$ Bn), 2018 - 2031
8.6.1.25. Rest of Middle East & Africa Sterile Injectable Drugs Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Route of Administration vs By Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Baxter International Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Sanofi
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Pfizer Inc.
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. GlaxoSmithKline plc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. AstraZeneca
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. GILEAD SCIENCES, INC.
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Merck & Co., Inc.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Novartis AG
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Johnson & Johnson Services, Inc.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Nova Nordisk A/S
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

Baxter International Inc.
Sanofi
Pfizer Inc.
GlaxoSmithKline plc.
AstraZeneca
GILEAD SCIENCES, INC.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson Services, Inc.
Nova Nordisk A/S

Methodology

LOADING...

High operational costs and discontinuation of products is anticipated to hinder revenue growth of the global sterile injectable drugs market

Demand for oncology drugs through sterile injections is expected to boost market growth in Europe

Key player strategies in the global sterile injectable drugs market

Key Companies Profiled

Global Sterile Injectable Drugs Market Segmentation

By Drug Type

By Application

By Route of Administration

By Molecule Type

By Distribution Channel

By Region

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Injectable Nanomedicines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Sterile Injectable Drugs - Global Strategic Business Report

Sterile Injectable Drugs Market by Molecule Type, Drug, Indication, Distribution - Global Forecast 2025-2030

Sterile Injectable Contract Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

Generic Oncology Sterile Injectable Global Market Report 2024